Chapter 173 - congenital vascular malformations endovascular management Flashcards
Classification of vascular anomalies by the International Society for the Study of Vascular Anomalies
TABLE 173.1
Vascular anomalies types
Vascular malformation 2/3 Vascular tumors 1/3
SE Mitchell vascular anomalies flow chart
FIGURE 173.1
TWIST sequence of MRI
contrast-enhanced Time-resolved angiography with interleaved stochastic trajectories
MRI features of vascular anomalies
TABLE 173.2
Hereditary venous malformations
1-2% of all venous malformations 1) glomuvenous malformation 2) cutaneous venous malformation 3) cerebral cavernous venous malformation 4) blue rubber bleb nevus syndrome
Histology of venous malformations
post-capillary endothelium lined venous channels with abnormal mural smooth muscle
Histology of lymphatic malformation
dysplastic endothelium-lined lymphatic channels
Hereditary lymphatic malformations
1) Turner syndrome 2) Noonan syndrome
VM and LM on MRI
Isointense to skeletal muscle on T1 hyperintense on T2 Intralesion hemorrhage will change signal depending on age of hemorrhage LM micro solid, macro cystic VM void areas corresponding to phlebolith
first line treatment for low flow vascular malformation
Sclerotherapy
Preoperative assessment for sclerotherapy for vascular malformation (low flow)
1) MRI to identify lesion and nearby structures 2) coagulation status (CBC, PTT, INR, fibrinogen, D-dimer) 3) LMWH if LIC for 10 days before and after treatment 4) status of deep venous system
Sclerosant used for vascular malformation treatment
1) ethanol 2) sodium tetradecyl sulfate 3) ethanolamine oleate 4) bleomycin 5) OK-432 Picibanil (LM)
Treatment of hematuria after sclerotherapy
Sclerosant-induced hemolysis hydration and urinary catheter
Complications of sclerosant injection
1) inflammatory complications 2) skin necrosis and wound infection due to extravasation 3) hematuria 4) acute compartment syndrome